Morphine-Methadone Opioid Rotation in Cancer Patients: Analysis of Dose Ratio Predicting Factors
Authors:
- Miguel Angel Benítez-RosarioMiguel Angel Benítez-Rosario
- Antonio Salinas-MartínASAntonio Salinas-Martín
- Armando Aguirre-JaimeAAArmando Aguirre-Jaime
- Lina Pérez-MéndezLPLina Pérez-Méndez
- Manuel FeriaMFManuel Feria
- 1 June 2009
- journal article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 37 (6) , 1061-1068
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Opioid Rotation from Morphine to Fentanyl in Delirious Cancer Patients: An Open-Label TrialJournal of Pain and Symptom Management, 2005
- Opioid switching to improve pain relief and drug tolerability2004
- The use of methadone for cancer painHematology/Oncology Clinics of North America, 2002
- Methadone Use in Cancer Patients with Pain: A ReviewJournal of Palliative Medicine, 2002
- Switching From Morphine to Methadone to Improve Analgesia and Tolerability in Cancer Patients: A Prospective StudyJournal of Clinical Oncology, 2001
- Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based ReportJournal of Clinical Oncology, 2001
- Opioid switch to oral methadone in cancer painCurrent Opinion in Oncology, 2000
- Opioid rotation for cancer painCancer, 1999
- Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?Journal of Clinical Oncology, 1998
- Dose ratio between morphine and methadone in patients with cancer painCancer, 1998